These success, along with a prior report demonstrating that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,two guidance the thought of targeting ACKR3 as a novel approach to modulate the opioid system, which could open up new therapeutic avenues for opioid-associated Conditions.Once in a while I get yourself a sligh